Johnson & Johnson Reaches Deal for $8.9 Billion Talc Settlementnews2023-04-05T01:25:02+00:00April 5th, 2023|The New York Times|
Texas Judge Hears Case to End Federal Approval of Abortion Pillnews2023-03-16T11:21:49+00:00March 16th, 2023|The New York Times|
How an Opioid Settlement Hinders Patients’ Access to ADHD Medication and Other Drugsnews2023-03-13T07:00:10+00:00March 13th, 2023|The New York Times|
Judge in Abortion Pill Case Set Hearing but Sought to Delay Telling the Publicnews2023-03-12T22:39:02+00:00March 12th, 2023|The New York Times|
Opioid Distributors Cleared of Liability to Georgia Families Ravaged by Addictionnews2023-03-02T02:54:45+00:00March 2nd, 2023|The New York Times|
12 States Sue F.D.A., Seeking Removal of Special Restrictions on Abortion Pillnews2023-02-24T23:20:38+00:00February 24th, 2023|The New York Times|
How a Drug Company Made $114 Billion by Gaming the U.S. Patent Systemnews2023-01-28T17:39:16+00:00January 28th, 2023|The New York Times|
A Dilemma for Governments: How to Pay for Million-Dollar Therapiesnews2023-01-25T00:27:17+00:00January 25th, 2023|The New York Times|
California Sues Companies Over Insulin Prices, Joining Other Statesnews2023-01-18T17:16:35+00:00January 18th, 2023|The New York Times|
Justice Dept. Sues AmerisourceBergen Over Role in Opioid Crisisnews2022-12-29T23:46:45+00:00December 29th, 2022|The New York Times|
